Laser assisted uvulopalatoplasty in sleep disordered breathing C Francis Ryan
Laser assisted uvulopalatoplasty (LAUP) is a new surgical recurrent occlusion of the upper airway during sleep. Upper airway occlusion can develop at various locations in the procedure for the treatment of snoring that is modelled on the uvulopalatopharyngoplasty (UPPP) operation for pharynx, but most commonly occurs at the level of the velopharynx, behind the soft palate. [10] [11] [12] [13] [14] Patients with OSA obstructive sleep apnoea (OSA). Since LAUP is technically simple, can be performed under local rather than general have been shown to have narrower upper airways, particularly at the level of the velopharynx. 11 15 16 Studies have anaesthetic, and is carried out in the doctor's surgery, it has received widespread publicity and its use has proliferated also indicated a more collapsible velopharynx in patients with OSA. 17 These abnormalities of size and function throughout Western Europe and North America. The rapid expansion in the use of LAUP has occurred despite a lack render the upper airway more susceptible to occlusion during sleep, in association with the sleep related decline of objective evidence regarding the indications, safety, and efficacy of this procedure for the treatment of snoring.
in upper airway dilator muscle activity. Nasal continuous positive airway pressure (CPAP) is the Furthermore, LAUP is now being offered as a treatment for OSA. Considering the recognised difficulty in distreatment of choice for patients with OSA who fail to respond to conservative measures. Nasal CPAP works tinguishing between simple snoring and OSA on clinical grounds alone, and the general infrequency with which by providing a pneumatic splint for the upper airway, preventing its collapse during sleep. 18 It is a highly effective preoperative sleep monitoring is performed prior to LAUP, it is likely that many patients with undiagnosed OSA are treatment for OSA. Unfortunately, because it is inherently cumbersome, up to 30% of patients are unable to tolerate undergoing LAUP for their snoring without due regard for the potential impact of this surgical procedure on their nasal CPAP therapy on a long term basis and are obliged to consider alternative treatments such as corrective upper sleep disordered breathing. There are many unanswered questions concerning the role of LAUP in the treatment airway surgery. In 1964 Ikematsu 19 first described the uvulopalatopharyngoplasty (UPPP) procedure for the of snoring and OSA. Until more objective data are available, prudence dictates a cautious approach to this new treattreatment of severe snoring which was subsequently modified for the treatment of OSA by Fujita et al. 20 The UPPP ment modality, including complete preoperative diagnosis, adequate postoperative follow up, and advice to patients procedure enlarges the upper airway by removing excess distal palatal tissue while preserving the function of the that LAUP is still an experimental procedure.
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Chronic snoring occurs in 20% of all adults.
2 Snoring proximal palatal musculature. The success of this operation varies considerably, and up to 60% of patients continue to is little more than a trivial nuisance for most people, but its importance as a symptom lies in its potential for social have significant OSA following it. 21 There are limited objective data regarding the long term efficacy of UPPP and marital disharmony, its association with increased cardiovascular morbidity, 3 4 and its relationship with more or the factors associated with a successful outcome. UPPP requires admission to hospital and general anaesthesia and serious respiratory sleep disorders such as OSA. Snoring is the most common presenting symptom of OSA. While is associated with significant early postoperative morbidity including pain, haemorrhage, velopharyngeal insufficiency, not all snorers have OSA, virtually every patient with OSA snores. Snoring is a predominantly inspiratory sound and nasopharyngeal stenosis. As a result it has not gained widespread acceptance for the treatment of simple snoring. arising from the pharynx during sleep. 5 The noise made by snoring, which can reach levels in excess of 85 decibels, Laser assisted uvulopalatoplasty is a new surgical technique first introduced by Kamami 22 for the treatment of is produced by vibration of the pharyngeal soft tissues (soft palate, tonsillar fauces, posterolateral oropharyngeal walls, snoring. It is a modification of the UPPP procedure that generally utilises a staged surgical approach and a less and base of the tongue). Snoring is probably caused by an unstable occlusion of the pharyngeal airway which, under radical resection of oropharyngeal tissue. The LAUP procedure is carried out in the doctor's surgery under local circumstances of increased inspiratory airflow resistance, behaves like a Starling resistor. 6 Any increase in inspiratory anaesthesia using a hand held CO 2 laser. A controlled resection of the uvula and soft palate is performed in 1-5 airflow resistance due to upper airway narrowing will predispose to snoring and upper airway occlusion during sleep.
stages at approximately monthly intervals until the desired outcome (elimination of snoring) is achieved. Healing and The similarities between the physiological events during sleep in snorers and patients with OSA, and the fact that scar contraction are associated with widening, stiffening, and elevation of the soft palate. OSA is usually preceded by decades of loud snoring, suggest that snoring constitutes the first stage in the natural From the perspective of the patient and the otolaryngologist, LAUP offers several potential advantages history of OSA.
Obstructive sleep apnoea is a relatively common conover other treatment options for snoring and OSA. The inconvenience and expense of a hospital admission, general dition that affects 1-4% of the adult population.
7 8 Although certain manifestations of this syndrome have been anaesthetic, and absence from work associated with a UPPP are avoided. In many instances LAUP is now offered described for many years, a wider recognition of its pathophysiology and clinical features has only occurred in the as a one stage procedure similar to a UPPP [23] [24] [25] and, as such, may be the cheapest therapeutic option currently available. last decade. 9 OSA is characterised by snoring and recurrent apnoea during sleep which results in episodic asphyxia and
In British Columbia, for instance, a one stage LAUP for the equivalent of £250 compares favourably with nasal interruption of the normal sleep pattern. In addition to disabling symptoms, patients with OSA may develop sig-CPAP therapy for £650 or an oral appliance for £750.
A successful LAUP may obviate the necessity for long term nificant complications such as systemic hypertension, heart failure, and cardiac arrhythmias. OSA occurs because of less convenient therapy such as lifestyle modification, nasal group.bmj.com on August 28, 2017 -Published by http://thorax.bmj.com/ Downloaded from CPAP, or an oral appliance. It is claimed that LAUP is patients being cured and 78% (range 67-95%) improved. The accuracy of self-reported data on snoring has been associated with less postoperative morbidity than UPPP. These potential advantages have resulted in the proquestioned, however. Miljeteig and coworkers 41 analysed questionnaire responses in 100 unselected patients who mulgation and widespread proliferation of LAUP in the absence of objective data to support its safety and efficacy.
underwent UPPP. The patients had no improvement in objective measures of apnoea and snoring on polyThis practice of uncontrolled development of surgical innovations is commonplace and by no means confined to somnography but had significant subjective improvement in the perception of snoring and quality of sleep by the upper airway surgery for snoring and OSA. 26 Whereas regulatory agencies play a major part in the development patient and bed partner. If patient and bed partner satisfaction were the only relevant end points in the treatment of new drugs and devices such as nasal CPAP, surgical procedures are relatively unregulated. Initial testing is of snoring, this discrepancy between subjective and objective outcomes would not matter a great deal. This usually carried out in an uncontrolled fashion and rarely subjected to the rigours of a randomised controlled trial. 27 ignores the fact, however, that snoring is a risk factor for cardiovascular disease and is commonly associated with Initial studies tend to suffer from numerous methodological limitations that render it difficult to interpret the results.
OSA, a condition with significant morbidity that may not be adequately treated by LAUP. This problem of relevant Such was the case with the literature on UPPP, whose deficiencies were well outlined recently in an extensive end points is compounded by the fact that many of the studies relied on patient histories to distinguish between review by Schechtman and colleagues. 28 A Medline search identified 87 articles on UPPP, of which only 37 had a simple snoring and OSA. There is ample evidence that clinical symptoms alone are inadequate to rule out sample size of 10 or more and a clear and unambiguous outcome measure. Among the 37 studies several important OSA. [42] [43] [44] [45] This issue was specifically addressed by Vaidya and associates 40 who attempted to develop a predictive methodological problems were identified including inadequate statistical power, absence of confidence bounds, model for the diagnosis of OSA based on questionnaires in 309 patients presenting for LAUP but were unable to uncontrolled design, inadequate follow up, uncertain generalisability, absence of quality of life assessment, multiple determine a group of symptoms or patient characteristics that reliably differentiated between apnoeic and nonend points, missing data, inconsistent definitions, and biased baseline data. The authors concluded that the cataapnoeic patients.
Only two studies reporting the results of LAUP for logue of information that remained unknown about UPPP was needlessly large. Upon reviewing the current literature the treatment of OSA had sufficient data to allow some assessment of efficacy. Walker and associates 35 reported 33 on LAUP it is clear that these methodological problems persist. It is likely therefore that large numbers of patients patients who had repeat polysomnography 4-6 weeks after LAUP. The operative technique consisted of vertical transhave undergone, and will continue to undergo, LAUP without the benefit of properly designed clinical trials to palatal incisions lateral to the uvula followed by subtotal uvulectomy. OSA was defined as a respiratory disturbance determine the potential risks and efficacy of this procedure.
For the reasons already outlined, it is difficult to glean index (RDI) of >5/hour, yet postoperative success was defined as an RDI of <10/hour. After LAUP 11 patients useful information from the 15 or so studies published to date on the use of LAUP for snoring and OSA. 22-25 29-40 (33%) had an RDI of <5/hour, 16 (48%) had an RDI of <10/hour, and 21 (64%) had a >50% reduction in RDI, Firstly, there is considerable variation in the surgical technique. Most studies report the use of a CO 2 laser, but five (15%) were unchanged, and seven (21%) were worse after LAUP. Mickelson and coworkers 37 obtained posttwo studies report a similar surgical procedure using electrocautery.
34 36 Six studies describe a technique of veroperative polysomnograms in 13 patients 6-8 weeks after LAUP. The operative procedure consisted of a staged tical transpalatal trench incisions lateral to the uvula combined with subtotal uvulectomy and variable resection of resection of the uvula and soft palate under local anaesthesia resulting in a postoperative appearance of the palatal and tonsillar tissue, 25 31 32 35 38 39 three studies describe a procedure similar to UPPP, 23 24 37 while yet another techpalate similar to UPPP. The mean (SD) apnoea index (AI) decreased from 19 (18)/hour to 4 (3)/hour (p=0.006), the nique called mucosal strip/uvulectomy consisting of a laser burn to a strip of ventral soft palate in conjunction with a RDI decreased from 31 (21)/hour to 16 (8)/hour (not significant), seven patients (54%) had a >50% reduction partial uvulectomy is also described. 30 33 In many studies additional surgery such as tonsillectomy, nasal turin RDI and five (38%) had an RDI of <10/hour after LAUP, and three patients (23%) were worse after the binectomy, or midline glossectomy was also performed. LAUP may be performed as a single stage resection or as operation. Superficially these results resemble those obtained by UPPP, but it is worth highlighting that in 21-23% a multi-staged sequential resection of palatal tissue until the desired therapeutic objective (elimination of snoring) of patients their OSA was worse after LAUP. Only limited data are available regarding the operative is attained. Given this heterogeneity of surgical technique, it is difficult to generalise from the results of individual risks and side effects of LAUP. Most reports indicate severe postoperative pain for 1-3 weeks. Carenfelt 23 reported that studies. In most studies patient selection criteria were unclear and preoperative sleep monitoring was not per-27% of patients developed slight or moderate scar fibrosis after LAUP compared with 14% of patients after UPPP. formed. Study end points were not clearly defined and postoperative sleep monitoring was rarely performed. ImTwo patients who underwent LAUP developed velopharyngeal stenosis that was made worse by reoperation provement in snoring was assessed by questionnaire data rather than objective measures. None of the studies used with UPPP. Velopharyngeal insufficiency was apparently infrequent and short lived. Since LAUP usually involves a a randomised controlled design, a power calculation for sample size, or an assessment of quality of life using a less radical resection of pharyngeal tissue than UPPP, there is the potential for early postoperative upper airway validated instrument, and no study had follow up beyond six months. Only two studies attempted any statistical obstruction secondary to oedema. This issue was addressed in a study by Terris and colleagues 38 who examined the analysis 33 38 or reported confidence limits. 33 Notwithstanding these methodological limitations, cereffects of LAUP on sleep disordered breathing and upper airway size in seven patients. Polysomnography, magnetic tain tentative observations can be made based on the available data. The reported efficacy of LAUP for alresonance imaging, and videoendoscopy of the upper airway were performed in each patient before and 48-72 leviating snoring varies, with 29% (range 5-84%) of group.bmj.com on August 28, 2017 -Published by http://thorax.bmj.com/ Downloaded from hours after LAUP. The AI increased from 3.3 (3.5)/hour other treatment modalities such as oral appliance therapy to enhance efficacy? Until the answers to these and other to 14.8 (10.9)/hour (p<0.03) and the RDI increased from 11.3 (10.9)/hour to 21.7 (9.9)/hour (not significant). The long term efficacy of LAUP has not been assessed cluding an objective measure of respiration during sleep, should be performed on patients undergoing LAUP for to date. Furthermore, the long term implications of eliminating the snoring noise in patients with OSA is unclear.
snoring. Patients should be informed that the risks, benefits, and complications of LAUP have not been established. Since it is likely that many patients currently undergoing LAUP for snoring have undiagnosed OSA, the reduction Those who undergo LAUP for snoring may incur the risk of a delay in diagnosing OSA and should be followed or elimination of their snoring may further delay a complete diagnosis in these patients, potentially leading to increased postoperatively. To this I would add the recommendation that a postoperative measure of respiration during sleep morbidity and mortality. The impact of a failed LAUP on subsequent treatment modalities for OSA is unknown.
be obtained, since an unsuccessful LAUP could convert simple snoring into obstructive apnoea. Otolaryngologists There is concern, for instance, that a failed UPPP decreases the likelihood of subsequent successful nasal CPAP therneed to be aware of the risk of perioperative upper airway obstruction following LAUP and take appropriate measapy. 47 The effect of an unsuccessful LAUP on subsequent nasal CPAP therapy is unknown.
ures to avoid this potentially lethal complication. Current treatment for snoring and OSA is far from To summarise the limited data currently available, it appears that the subjective efficacy of LAUP for the relief satisfactory and there is no room for complacency. Corrective upper airway surgery, including LAUP, undoubtedly of snoring, and the objective efficacy for the treatment of OSA, are no better than UPPP. Variations in surgical has a part to play in the treatment of these disorders. The challenge remains to delineate this role as precisely and as technique may actually predispose to an increased risk of postoperative velopharyngeal stenosis compared with expeditiously as possible. Many questions regarding LAUP remain unanswered.
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Is it still possible to assess this new surgical procedure sessment be used to select the patients most likely to obtain 
